| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/19/2002 | EP0814831B1 Medicaments for treatment of autoimmune diseases using interferon-tau |
| 06/19/2002 | EP0800520B1 Process for the preparation of lamotrigine |
| 06/19/2002 | EP0754061B1 New oral pharmaceutical dosage form |
| 06/19/2002 | EP0753302B1 Osteoporosis preventing or treating agent |
| 06/19/2002 | EP0750504B1 Use of complex carbohydrate to diminish hypoglycemia in patients with diabetes mellitus |
| 06/19/2002 | EP0730474B1 Estramustine formulations with improved pharmaceutical properties |
| 06/19/2002 | EP0634932B1 Method for reducing intraocular pressure in the mammalian eye by administration of muscarinic antagonists |
| 06/19/2002 | EP0625204B1 Hepatitis therapeutics |
| 06/19/2002 | EP0574487B1 Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b |
| 06/19/2002 | CN1354798A Process for preparation of pseudomonic acid A antibiotic by microbiological method |
| 06/19/2002 | CN1354755A Nucleotide and protein sequence of Nogo genes and methods based thereon |
| 06/19/2002 | CN1354754A Injectable anthelmintic formulation |
| 06/19/2002 | CN1354750A Amine derivatives compounds |
| 06/19/2002 | CN1354749A Use of selective antagonists of 1b-adrenergic receptor for improvement of sexual dysfunction |
| 06/19/2002 | CN1354747A 2-amino-4H-3.1-benzoxazinone-4-keto derivatives for treatment of obesity |
| 06/19/2002 | CN1354746A 6.7-disubstituted-5,8-quinolinedione derivatives as antifungal agent |
| 06/19/2002 | CN1354745A Ethanesulfonyl-piperidine derivatives |
| 06/19/2002 | CN1354744A Crystaline forms of sodium salt of 5-chloro-2-methoxy-N-(2(4-methoxy-3-methylaminothio carbonylamino sulfonylphenyl)ethyl) benzamide |
| 06/19/2002 | CN1354742A Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor (PPAR)a |
| 06/19/2002 | CN1354740A Pharmaceutical compounds |
| 06/19/2002 | CN1354737A Novel derivatives of 3-3-diphenylpropylamines |
| 06/19/2002 | CN1354678A Polyethyleneimine: DNA formulations for aerosol delivery |
| 06/19/2002 | CN1354677A Topical compositions for prostaglandin E1 delivery |
| 06/19/2002 | CN1354676A Amnotetralin derivative for therapy of cardiovascular diseases |
| 06/19/2002 | CN1354673A New dialysis method |
| 06/19/2002 | CN1354667A Use of camptotheicin derivatives with reduced gastrointestinal toxicity |
| 06/19/2002 | CN1354666A Lower toxicity and anti-inflammatory and anti-exudation pharmaceutical composition |
| 06/19/2002 | CN1354665A Sustained release ranolazine formulations |
| 06/19/2002 | CN1354664A Injectable naltrexone microsphere compositions and their use in reducing consumption of heroinb and alcohol |
| 06/19/2002 | CN1354663A Sulfonamide and sulfamide substituted imidazoquinolines |
| 06/19/2002 | CN1354662A Use of osanetant in pharmaceutical preparation for treatment of mood disorders |
| 06/19/2002 | CN1354661A Novel method of treatment |
| 06/19/2002 | CN1354660A Orally administrable pharmaceutical preparation having therapeutic effect on gastrointestinal disorders comprising coated ranitidine, bismuth subcitrate and sucralfate |
| 06/19/2002 | CN1354659A Novel diphenylethylene compounds |
| 06/19/2002 | CN1354658A New use of compounds as antibacterial agents |
| 06/19/2002 | CN1354657A EGF-R antagonists for treating hypersecretion of mucus in lungs |
| 06/19/2002 | CN1354656A Compositions and methods for mucosal delivery |
| 06/19/2002 | CN1354655A Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents |
| 06/19/2002 | CN1354654A Transdermal therapeutic system with neutralized pressure sensitiivty acrylic adhesive patch |
| 06/19/2002 | CN1354653A Compressed compositions comprising clarified xanthan gum |
| 06/19/2002 | CN1354652A Milling process for production of finely milled medicinal substances |
| 06/19/2002 | CN1354640A Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
| 06/19/2002 | CN1354622A Prostaglandin compound, compositions and methods of treating peripheral vascular disease and pulmonary hypertension |
| 06/19/2002 | CN1354187A Hen egg yolk antibody for resisting pyloric helicobacterium cytotoxin, its preparation and application |
| 06/19/2002 | CN1354184A Method for synthesizing 2-methoxyestradiol and application of its product |
| 06/19/2002 | CN1354171A Catalytic reduction of acetylene hydrocarbon compound |
| 06/19/2002 | CN1353992A Notoginsenoside enteric tablet |
| 06/19/2002 | CN1353991A Ginsenoside enteric tablet |
| 06/19/2002 | CN1353990A Preparation for analgesia and anesthesia or curing drug dependence |
| 06/19/2002 | CN1353989A Medicine for curing angiopathy |
| 06/19/2002 | CN1353988A Medicine for curing osteopathy |
| 06/19/2002 | CN1353987A Medicine for curing myeloproliferative abnormal syndrome |
| 06/19/2002 | CN1353986A Antibiotic agent of antihelicobacter pylori containing chelate compound |
| 06/19/2002 | CN1353985A Matter or composition for treatment of cancer |
| 06/19/2002 | CN1353981A Quick-acting aerosol for resisting angina cordis and its preparation method |
| 06/19/2002 | CN1353980A Quick-acting aerosol for relieving asthma and its preparation method |
| 06/19/2002 | CN1353978A Poria type nucleic acid compound preparation and its external application preparation and cosmetics, and their production method |
| 06/19/2002 | CN1086389C Isoesperamicin and its synthesizing process |
| 06/19/2002 | CN1086387C N-(aryloxyalkyl)heteroarylpiperidines and heteroarylpiperazines, their preparing method and their use as medicine |
| 06/19/2002 | CN1086386C Multi-drug resistance modifier |
| 06/19/2002 | CN1086385C Methanesulphonate salt of arylpiperzine derived from tryptamine and its solvates for pharmaceutical use |
| 06/19/2002 | CN1086297C Chinese medicinal pill for treating gynaopathy |
| 06/19/2002 | CN1086291C Primary and secondary neuroprotective effect of flupirtine in neurodegenerative diseases |
| 06/19/2002 | CN1086290C Composition for treating condyloma acuminata |
| 06/19/2002 | CN1086289C Use of rhein or its salt in preparation of medicine for curing diabetes and nephrosis |
| 06/19/2002 | CN1086277C Method to prepare food seasoning, food ingredient and food item compositions, seasoning and use thereof |
| 06/18/2002 | US6407288 Naphthylsalicylanilides as antimicrobial and antiinflammatory agents |
| 06/18/2002 | US6407278 Stable amorphous amifostine compositions and methods for the preparation and use of the same |
| 06/18/2002 | US6407267 Method for the preparation of citalopram |
| 06/18/2002 | US6407257 Derivatives of erythromycin, their preparation process and their use as medicaments |
| 06/18/2002 | US6407255 Chemical synthesis of 1,2,4-triazolinone derivative |
| 06/18/2002 | US6407250 Interphenylene 7-oxabicyclic [2.2.1] heptane oxazoles as prostaglandin F2a antagonists |
| 06/18/2002 | US6407249 Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group |
| 06/18/2002 | US6407246 Reverse transcriptase inhibitors to treat hiv |
| 06/18/2002 | US6407244 Antiproliferative agent |
| 06/18/2002 | US6407240 Reduction of the corresponding ester; reacting with iminium salt |
| 06/18/2002 | US6407239 Topoisomerase inhibitors |
| 06/18/2002 | US6407237 Crystal forms of 9-substituted hypoxanthine derivatives |
| 06/18/2002 | US6407236 Tumor diagnosis; antiinflammatory agents; antiischemic agents; antidepressants |
| 06/18/2002 | US6407235 Prodrug acid esters of [2-(4-benzyl-3-hydroxy-piperidin-1-yl)-ethansulfonyl]phenol |
| 06/18/2002 | US6407142 Use of stilbene derivatives substituted in position 3 as deodorant active agents in cosmetic compositions |
| 06/18/2002 | US6407141 Arteriosclerosis, atherosclerosis, endocarditis, fatty buildup, and microbial infections; cardiovascular disorders; hemotherapy |
| 06/18/2002 | US6407140 Autoimmune diseases, graft versus host disease and organ transplant surgery; pyrazole derivative mixture |
| 06/18/2002 | US6407139 Administering n-(3,4-dimethoxycinnamoyl)anthranilic acid or salt as antitumor or anticarcinogenic agent |
| 06/18/2002 | US6407137 Dopamine analog amide |
| 06/18/2002 | US6407135 Conjugates of dithiocarbamates with pharmacologically active agents and uses therefor |
| 06/18/2002 | US6407133 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 06/18/2002 | US6407131 5-carbonyloxy-1h-benzimidazole-2-carbamate derivatives |
| 06/18/2002 | US6407129 Azole compounds, their production and their use |
| 06/18/2002 | US6407128 Method for increasing the bioavailability of metaxalone |
| 06/18/2002 | US6407125 Administering 2-carboxypyridine derivative to treat skin, respiratory system, and immune disorders; anticarcinogenic, antiinflammatory and antiviral agents; deactivating metal-protein complexes |
| 06/18/2002 | US6407123 Diaminopyridine-containing thiourea inhibitors of herpes viruses |
| 06/18/2002 | US6407122 Neuroprotective agents, antiischemic, and hyperglycemic agents; huntington*s, parkinson*s, and alzheimer*s disease;amyotrophic lateral sclerosis treatment; nervous system and brain disorders |
| 06/18/2002 | US6407118 Antitumor agents; side effect reduction |
| 06/18/2002 | US6407117 Administering irinotecan hydrochloride and bicarbonate to maintain intestinal lumen alkalinity and prevent diarrhea; aids treatment |
| 06/18/2002 | US6407114 Pyrazolopyrimidinone CGMP PDE5 inhibitors for the treatment of sexual dysfunction |
| 06/18/2002 | US6407113 2-(1-piperazinyl)-5-methylbenzenesulfonic acid derivative or its salt, or hydrate or solvate; improve abnormal intracellular handling calcium ion |
| 06/18/2002 | US6407111 Phenyl substituted pyridine and benzene derivatives |
| 06/18/2002 | US6407110 Polyhydroxyalkylpyrazine derivatives and their preparation and medicines containing them |
| 06/18/2002 | US6407109 Antiepiletic, antidepressant, and anxiolytic agents; psychological and nervous system disorders |